These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2208396)
1. Synthesis of a new chemically stable prostacyclin analogue with high and long-lasting activity. Iseki K; Kanayama T; Hayasi Y; Shibasaki M Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1769-71. PubMed ID: 2208396 [TBL] [Abstract][Full Text] [Related]
2. A novel homoisocarbacyclin analog with potent and long-lasting activity. Shibasaki M; Takahashi A; Aoki T; Sato H; Yamada S; Kudo M; Kogi K; Narita S Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):279-81. PubMed ID: 1576688 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of a new chemically and metabolically stable prostacyclin analogue with high and long-lasting oral activity. Skuballa W; Schillinger E; Stürzebecher CS; Vorbrüggen H J Med Chem; 1986 Mar; 29(3):313-5. PubMed ID: 2419560 [No Abstract] [Full Text] [Related]
4. Synthesis of 3-oxa-5-alkylideneisocarbacyclins. Kojima K; Amemiya S Chem Pharm Bull (Tokyo); 1993 May; 41(5):913-8. PubMed ID: 8339338 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of ZK-96,480: a chemically and metabolically stable potent prostacyclin analogue. Skuballa W; Vorbrüggen H Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():271-3. PubMed ID: 2418656 [No Abstract] [Full Text] [Related]
6. Stereocontrolled synthesis of exocyclic olefins using arene tricarbonyl chromium complex-catalyzed hydrogenation. I. Efficient synthesis of carbacyclin and its analogs. Sodeoka M; Ogawa Y; Kirio Y; Shibasaki M Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):309-22. PubMed ID: 2054856 [TBL] [Abstract][Full Text] [Related]
8. Syntheses and biological activities of chemically stable prostacyclin mimics with cis-bicyclo[4.3.0]nonene ring system: the novel homoisocarbacyclin analogues. Narita S; Takahashi A; Aoki T; Sato H; Satoh S; Yamada S; Kudo M; Yamaguchi T; Kogi K; Shibasaki M Bioorg Med Chem; 1993 Aug; 1(2):77-118. PubMed ID: 8081847 [TBL] [Abstract][Full Text] [Related]
9. Studies on structure-activity relationships of prostacyclin analogs based on molecular mechanics and molecular orbital methods. Miyamoto S; Yoshimoto M Chem Pharm Bull (Tokyo); 1987 Nov; 35(11):4510-6. PubMed ID: 3327624 [No Abstract] [Full Text] [Related]
10. [Research and development of beraprost sodium, a new stable PGI2 analogue]. Nishio S; Nagase H; Kanou K; Aoki S; Kanbayashi Y Yakugaku Zasshi; 1997 Aug; 117(8):509-21. PubMed ID: 9306726 [TBL] [Abstract][Full Text] [Related]
11. [Synthesis and antiaggregation activity of prostacyclin analogs. II. Direct synthesis of 15-fluoro-13,14-didehydrocarbacyclin]. Lopp MI; Bergmann MA; Bezuglov VV; Vialimiaé TK; Lopp AKh Bioorg Khim; 1988 Jun; 14(6):834-8. PubMed ID: 3056417 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of a highly potent analogue of prostacyclin, (-)-5-methyleneisocarbacyclin. Amemiya S; Koyama K; Saito S; Kojima K Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4403-5. PubMed ID: 3549013 [No Abstract] [Full Text] [Related]
13. Synthesis of ciloprost (ZK 36 374): a chemically stable and biologically potent prostacyclin analog. Skuballa W; Vorbrüggen H Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():299-305. PubMed ID: 6189381 [No Abstract] [Full Text] [Related]
14. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog. Kanayama T; Kimura Y; Iseki K; Hayashi Y; Tamao Y; Mizogami S J Pharmacol Exp Ther; 1990 Dec; 255(3):1210-7. PubMed ID: 1702154 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of human platelet aggregation by stable analogs of prostacyclin. Togna G; GAndolfi C; Andreoni A; Fumagalli A; Passarotti C; Faustini F; Patrono C Pharmacol Res Commun; 1977 Nov; 9(10):909-16. PubMed ID: 343117 [No Abstract] [Full Text] [Related]
16. Antithrombotic management with a stable prostacyclin analogue during extracorporeal circulation. Maurin N Contrib Nephrol; 1991; 93():205-9. PubMed ID: 1802582 [No Abstract] [Full Text] [Related]
17. Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat. Stürzebecher S; Haberey M; Müller B; Schillinger E; Schröder G; Skuballa W; Stock G; Vorbrüggen H; Witt W Prostaglandins; 1986 Jan; 31(1):95-109. PubMed ID: 3513260 [TBL] [Abstract][Full Text] [Related]
18. Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers. Belch JJ; McLaren M; Lau CS; Mackay IR; Bancroft A; McEwen J; Thompson JM Br J Clin Pharmacol; 1993 Jun; 35(6):643-7. PubMed ID: 8329292 [TBL] [Abstract][Full Text] [Related]
19. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting. Michel G; Seipp U Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087 [TBL] [Abstract][Full Text] [Related]
20. Control of human and animal platelet aggregation by a new prostacyclin analog. Maderna P; Colli S; Sirtori C; Tremoli E; Paoletti R Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():363-9. PubMed ID: 2408447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]